Pharm Exam 1: Carbidopa-Levodopa
12 Questions
100 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the pharmacologic classification for Carbidopa-Levodopa?

Dopamine Agonist

What is indicated for the use of Carbidopa-Levodopa?

Parkinson's Disease

What are the therapeutic goals/actions for Carbidopa-Levodopa? (Select all that apply)

  • Inhibition of dopamine breakdown (correct)
  • Higher levels of dopamine
  • Relief of tremor and rigidity (correct)
  • Decrease heart rate
  • What is converted into dopamine?

    <p>Levodopa</p> Signup and view all the answers

    What is an inhibitor that prevents the breakdown of dopamine?

    <p>Carbidopa</p> Signup and view all the answers

    Carbidopa crosses the blood-brain barrier (BBB).

    <p>False</p> Signup and view all the answers

    Which conditions are contraindicated for Carbidopa-Levodopa? (Select all that apply)

    <p>Melanoma</p> Signup and view all the answers

    What are some adverse effects of Carbidopa-Levodopa? (Select all that apply)

    <p>Darkens sweat and urine</p> Signup and view all the answers

    Which medications interact with Carbidopa-Levodopa? (Select all that apply)

    <p>Benzodiazepines</p> Signup and view all the answers

    What does the 'wearing off' effect refer to?

    <p>'Wearing off' refers to diminished effectiveness after 5-10 years of use.</p> Signup and view all the answers

    What are some patient education points regarding Carbidopa-Levodopa?

    <p>High protein diet impairs levodopa's function, Vitamin B6 can interfere, and monitor for wearing off effect.</p> Signup and view all the answers

    What are the desired outcomes for patients taking Carbidopa-Levodopa?

    <p>Resolutions of PD signs/symptoms.</p> Signup and view all the answers

    Study Notes

    Pharmacologic Classification

    • Carbidopa-Levodopa is classified as a dopamine agonist.

    Indications

    • Primarily indicated for the treatment of Parkinson's Disease.

    Therapeutic Goals and Actions

    • Aims to provide relief from tremors and rigidity in patients with Parkinson's Disease.
    • Levodopa is converted into dopamine in the brain to enhance motor function.
    • Carbidopa inhibits the enzyme that breaks down dopamine, increasing its availability in the brain.

    Key Components

    • Levodopa is the substance that gets converted into dopamine.
    • Carbidopa prevents the breakdown of dopamine, enhancing the effectiveness of Levodopa.

    Pharmacokinetics

    • Carbidopa does not cross the blood-brain barrier but can cross the placenta.
    • Both Carbidopa and Levodopa are excreted in breast milk.

    Contraindications

    • Not recommended for patients with glaucoma.
    • Caution advised for individuals with melanoma.

    Adverse Effects

    • Potential side effects include dyskinesia, nausea, and vomiting.
    • Can lead to melanoma, darkened sweat and urine, cardiac dysrhythmias, hypotension, and muscle cramps.

    Drug Interactions

    • Non-selective MAOIs can interact negatively with Carbidopa-Levodopa.
    • Interactions with benzodiazepines, antipsychotics, and vitamin B6 (Pyridoxine) can occur.
    • Dietary protein may impair the effectiveness of Levodopa.
    • Anticholinergics may work in conjunction with cholinergic medications.

    Nurse Safety Considerations

    • "Wearing off" phenomenon may occur, where the medication loses effectiveness over time (5-10 years).
    • "Wearing on/off" phenomenon affects some patients, fluctuating between symptom control and lack of control.

    Patient Education

    • Advise against a high-protein diet, which can impair Levodopa absorption.
    • Monitor for indications of melanoma risk.
    • Educate patients that vitamin B6 can interfere with Levodopa's effectiveness.
    • Discuss the "wearing off" effect and its potential impact on treatment.

    Outcomes

    • Expected to see resolutions of Parkinson's Disease signs and symptoms.
    • Therapeutic effects can take anywhere from 2-3 weeks to 6 months to manifest fully.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on Carbidopa-Levodopa, its pharmacologic classification, indications for use in Parkinson's Disease, and its therapeutic goals. This quiz will help reinforce your understanding of this essential anti-Parkinson's medication.

    More Like This

    Use Quizgecko on...
    Browser
    Browser